Alliance for Aging Research Congratulates Dr. Stephen Hahn on Appointment to FDA Commissioner
Published December 13, 2019
December 13th, 2019 – Yesterday the Senate confirmed Dr. Stephen Hahn as the Commissioner of the U.S. Food and Drug Administration. The Alliance for Aging Research commends the Administration and the Senate for appointing Dr. Hahn to this important role. The Alliance congratulates Dr. Hahn on his appointment and we look forward to working with him.
On November 18, the Alliance sent a letter to the Senate Committee on Health, Education, Labor and Pensions outlining its support for Dr. Hahn as FDA Commissioner. Click here to read the letter.
About the Alliance for Aging Research
The Alliance for Aging Research is the leading nonprofit organization dedicated to accelerating the pace of scientific discoveries and their application to vastly improve the universal human experience of aging and health. The Alliance believes advances in research help people live longer, happier, more productive lives and reduce healthcare costs over the long term. For more than 30 years, the Alliance has guided efforts to substantially increase funding and focus for aging at the National Institutes of Health and Food and Drug Administration; built influential coalitions to guide groundbreaking regulatory improvements for age-related diseases; and created award-winning, high-impact educational materials to improve the health and well-being of older adults and their family caregivers. For more information, visit www.agingresearch.org